NCT00828204 - Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions

Multiple Sclerosis

Interventions

DEVICE

single-use autoinjector with a prefilled liquid Avonex syringe

DEVICE

Avonex prefilled syringe via manual IM injection

DRUG

BG9418 (interferon beta-1a)

Trial Locations (16)

2135

Research Site, Boston

4320

Neurology & Neuroscience Associates, Inc., Akron

11772

Comprehensive Multiple Sclerosis Care Center, Patchogue

14203

Research Site, Buffalo

23298

Research Site, Richmond

25301

Research Site, Charleston

28207

Research Site, Charlotte

28595

Michigan Institute for Neurological Disorders, Farmington Hills

30327

Research Site, Atlanta

32751

Research Site, Maitland

46804

Fort Wayne Neurological Center, Fort Wayne

75214

Research Site, Dallas

78681

Research Site, Round Rock

84103

Research Site, Salt Lake City

85018

Research Site, Phoenix

85234

Research Site, Gilbert